Nevisense Electrical Impedance Spectroscopy to Test Lesions Before Biopsy for Melanoma

SciBase, a Swedish firm, won FDA approval to introduce its Nevisense system to help dermatologists assess suspect cutaneous lesions that may be melanoma tumors. Unlike many technologies that have been attempted to characterize cancerous lesions, this...

Source: Medgadget - July 5, 2017 Category: Medical Devices Authors: Editors Tags: Dermatology Source Type: blogs